| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Osteopetrosis | |||||
| 2 | More general conditions related to this trial | ||||
| Bone Diseases | |||||
| Bone Diseases, Developmental | |||||
| Musculoskeletal Diseases | |||||
| Osteochondrodysplasias | |||||
| Osteosclerosis | |||||
| 3 | Interventions listed in this trial | ||||
| calcitriol | |||||
| interferon gamma | |||||
| 4 | Additional drug interventions recognized in this trial | ||||
| Interferon Alfa-2b | |||||
| Interferon Type II | |||||
| Interferon-gamma, Recombinant | |||||
| Interferons | |||||
| 5 | More general drug interventions related to this trial | ||||
| Angiogenesis Inhibitors | |||||
| Angiogenesis Modulating Agents | |||||
| Anti-Infective Agents | |||||
| Antineoplastic Agents | |||||
| Antiviral Agents | |||||
| Bone Density Conservation Agents | |||||
| Calcium Channel Agonists | |||||
| Cardiovascular Agents | |||||
| Growth Inhibitors | |||||
| Growth Substances | |||||
| Membrane Transport Modulators | |||||
| Micronutrients | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Therapeutic Uses | |||||
| Vasoconstrictor Agents | |||||
| Vitamins | |||||
| 6 | Sponsors listed in this trial | ||||
| FDA Office of Orphan Products Development | |||||
| Medical University of South Carolina | |||||
|
